Alysha J. Sekhon

Alysha J. Sekhon is Counsel in the Firm’s Intellectual Property Practice and Privacy and Cybersecurity Practice and is recognized as a “Rising Star” in Technology Transactions by The Legal 500. She advises on all intellectual property, privacy, cybersecurity, artificial intelligence and technology aspects of complex corporate transactions, including mergers and acquisitions, divestitures, carve outs, investments, spin-offs and capital markets and financing transactions, and on the structuring and negotiation of standalone intellectual property transactions, including in the context of strategic alliances and joint ventures, collaboration and development agreements, license agreements, long-term services agreements and distribution agreements. Alysha counsels clients in a variety of industries, including entertainment, media and sports, software and technology, apparel, retail and consumer products, food and agriculture, healthcare and life sciences, education, social and digital media, banking and financial services and nonprofits. She has also advised on the successful resolution of intellectual property disputes.

Alysha’s representative engagements include:

• Blackstone in multiple transactions, including its acquisitions of PSAV and Ancestry.com, take-private of Tricon Residential, partnership with Thomson Reuters, sale of Refinitiv and majority stake in Spanx, Supergoop! and Emerson’s climate technologies business;
• Silver Lake in its acquisition of Endeavor Group Holdings, Inc. at an equity value of $13 billion and a $25 billion enterprise value;
• KKR in its approximately $4 billion acquisition of Broadcom’s End-User Computing Division;
• Silver Lake-backed Software AG in its sale of StreamSets and webMethods to IBM for €2.13 billion;
• Avantor in its $4.37 billion initial public offering and its $2.9 billion acquisition of the Masterflex bioprocessing business and related assets of Antylia Scientific;
• The Bountiful Company in its acquisition by Nestlé for $5.75 billion;
• AGCO in its entry into a joint venture with Trimble;
• Digital Colony and EQT Infrastructure in its $14.3 billion acquisition of Zayo;
• G-III Apparel in its acquisition of Karl Lagerfeld Brand;
• Clariant AG in its acquisition of Lucas Meyer Cosmetics from International Flavors & Fragrances, Inc. for $810 million in cash;
• New Mountain Capital in its acquisition of Broadcast Music;
• Grupo Axo in its formation of a joint venture with The TJX Companies in Mexico;
• KKR in its acquisition of OverDrive and Kanopy;
• Mars Petcare in its acquisition of Vetsource;
• Silver Lake as co-lead investor in Alchemy;
• Laureate Education in its sale of Walden University to Adtalem Global Education and its Brazilian operations to Ser Educacional;
• Quirch Foods in its acquisition of Colorado Boxed Beef;
• Underwriters in the IPOs of Atmus, JOANN, Frequency Therapeutics and Sotera Heath;
• 3Z in its acquisition of Southerland;
• Initial purchasers, led by J.P. Morgan, in $1 billion senior notes offering by Lions Gate Entertainment;
• Johnson Controls in its sale of Residential and Light Commercial HVAC Businesses to Bosch Group for $8.1 billion;
• Goldman Sachs Asset Management in its investment in in CarltonOne;
• Garda World Securities Corporation in its acquisitions of ARCA Holdings, Tidel and Gunnebo Group;
• Transaction Data Systems in merger of the Outcomes business of Cardinal Health into Transaction Data Systems;
• TWC Tech Holdings II Corp, a SPAC, in its combination with Cellebrite;
• Laborie Medical Technologies in its investment in Bright Uro and acquisitions of GI Supply and Urotronic;
• Vyaire Medical in the sale of its consumables business to SunMed;
• Prometheus Group in connection with its acquisition of Atonix Digital;
• The NPD Group and Hellman & Friedman in connection with Information Resources, Inc.’s merger with the NPD Group;
• Change Healthcare in its $13.8 billion acquisition by UnitedHealth Group and the $2.2 billion divestiture of Change’s ClaimsXten business unit; and
• CSL Behring in its acquisition of Vitaeris and the exclusive global license rights to commercialize an adeno-associated virus (AAV) gene therapy program for the treatment of hemophilia B.

Alysha received her J.D. from the New York University School of Law in 2017. She received her B.A. from Stanford University in 2013.